Iota Biosciences competitors

Develops the Evoke closed-loop spinal cord stimulation system, the first SCS device that senses the spinal cord's ECAP response and adjusts therapy on every pulse.

Spinal & Peripheral Interfaces · IPO $150M

Spinal & Peripheral Interfaces

IPO

$150M

HQ

Develops spinal cord stimulation platforms to restore movement and function in patients with spinal cord injury.

Spinal & Peripheral Interfaces · IPO $89.6M

Spinal & Peripheral Interfaces

IPO

$89.6M

HQ